Regan M. LeBlanc

754 total citations
25 papers, 627 citations indexed

About

Regan M. LeBlanc is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Regan M. LeBlanc has authored 25 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Regan M. LeBlanc's work include RNA and protein synthesis mechanisms (13 papers), RNA modifications and cancer (10 papers) and Synthesis and biological activity (6 papers). Regan M. LeBlanc is often cited by papers focused on RNA and protein synthesis mechanisms (13 papers), RNA modifications and cancer (10 papers) and Synthesis and biological activity (6 papers). Regan M. LeBlanc collaborates with scholars based in United States, Austria and Italy. Regan M. LeBlanc's co-authors include T. Kwaku Dayie, Herman Holt, Moses Lee, Andrew P. Longhini, Toni Brown, Bin Chen, Hari N. Pati, Christoph Kreutz, Susan L. Mooberry and Hilary Mackay and has published in prestigious journals such as Nucleic Acids Research, Angewandte Chemie International Edition and Methods in enzymology on CD-ROM/Methods in enzymology.

In The Last Decade

Regan M. LeBlanc

23 papers receiving 619 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Regan M. LeBlanc United States 14 379 289 55 46 25 25 627
Аndrey V. Shernyukov Russia 13 210 0.6× 168 0.6× 53 1.0× 31 0.7× 12 0.5× 36 474
András Földesi Sweden 18 676 1.8× 353 1.2× 145 2.6× 39 0.8× 20 0.8× 73 1.1k
Surat Kumar India 14 511 1.3× 133 0.5× 34 0.6× 52 1.1× 16 0.6× 16 619
Ugo Perricone Italy 15 316 0.8× 134 0.5× 13 0.2× 40 0.9× 18 0.7× 40 545
Philip M. Dean United Kingdom 15 551 1.5× 154 0.5× 80 1.5× 54 1.2× 16 0.6× 25 752
Charles E. Cottrell United States 13 170 0.4× 220 0.8× 111 2.0× 46 1.0× 7 0.3× 30 502
Joseph Ashcroft United States 13 271 0.7× 266 0.9× 33 0.6× 136 3.0× 35 1.4× 23 484
Marek Masnyk Poland 15 275 0.7× 316 1.1× 102 1.9× 37 0.8× 8 0.3× 55 621
Yadagiri Bathini Canada 14 516 1.4× 279 1.0× 22 0.4× 31 0.7× 37 1.5× 20 699
Christopher Smith United Kingdom 12 130 0.3× 211 0.7× 29 0.5× 75 1.6× 12 0.5× 23 344

Countries citing papers authored by Regan M. LeBlanc

Since Specialization
Citations

This map shows the geographic impact of Regan M. LeBlanc's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regan M. LeBlanc with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regan M. LeBlanc more than expected).

Fields of papers citing papers by Regan M. LeBlanc

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regan M. LeBlanc. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regan M. LeBlanc. The network helps show where Regan M. LeBlanc may publish in the future.

Co-authorship network of co-authors of Regan M. LeBlanc

This figure shows the co-authorship network connecting the top 25 collaborators of Regan M. LeBlanc. A scholar is included among the top collaborators of Regan M. LeBlanc based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regan M. LeBlanc. Regan M. LeBlanc is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
LeBlanc, Regan M., et al.. (2023). Hepatitis B Virus Epsilon (ε) RNA Element: Dynamic Regulator of Viral Replication and Attractive Therapeutic Target. Viruses. 15(9). 1913–1913. 3 indexed citations
2.
LeBlanc, Regan M., et al.. (2022). Extraction and Purification of (E)-Resveratrol from the Bark of Conifer Species. Processes. 10(4). 647–647. 10 indexed citations
3.
LeBlanc, Regan M., et al.. (2021). Isotope-Labeled RNA Building Blocks for NMR Structure and Dynamics Studies. Molecules. 26(18). 5581–5581. 10 indexed citations
4.
LeBlanc, Regan M. & Michael F. Mesleh. (2020). A drug discovery toolbox for Nuclear Magnetic Resonance (NMR) characterization of ligands and their targets. Drug Discovery Today Technologies. 37. 51–60. 4 indexed citations
5.
LeBlanc, Regan M., et al.. (2020). Deleterious effects of carbon–carbon dipolar coupling on RNA NMR dynamics. Journal of Biomolecular NMR. 74(6-7). 321–331. 8 indexed citations
6.
LeBlanc, Regan M., Andrew P. Longhini, Vitali Tugarinov, & T. Kwaku Dayie. (2018). NMR probing of invisible excited states using selectively labeled RNAs. Journal of Biomolecular NMR. 71(3). 165–172. 13 indexed citations
7.
Roy, Susmita, Heiko Lammert, Ryan L. Hayes, et al.. (2017). A magnesium-induced triplex pre-organizes the SAM-II riboswitch. PLoS Computational Biology. 13(3). e1005406–e1005406. 29 indexed citations
8.
Longhini, Andrew P., Regan M. LeBlanc, & T. Kwaku Dayie. (2016). Chemo-enzymatic labeling for rapid assignment of RNA molecules. Methods. 103. 11–17. 13 indexed citations
9.
Chen, Bin, Regan M. LeBlanc, & T. Kwaku Dayie. (2016). SAM‐II Riboswitch Samples at least Two Conformations in Solution in the Absence of Ligand: Implications for Recognition. Angewandte Chemie International Edition. 55(8). 2724–2727. 35 indexed citations
10.
Chen, Bin, Regan M. LeBlanc, & T. Kwaku Dayie. (2016). SAM‐II Riboswitch Samples at least Two Conformations in Solution in the Absence of Ligand: Implications for Recognition. Angewandte Chemie. 128(8). 2774–2777. 5 indexed citations
11.
Wunderlich, Christoph H., Michael Andreas Juen, Regan M. LeBlanc, et al.. (2015). Stable Isotope-Labeled RNA Phosphoramidites to Facilitate Dynamics by NMR. Methods in enzymology on CD-ROM/Methods in enzymology. 565. 461–494. 20 indexed citations
12.
Alvarado, Luigi J., Regan M. LeBlanc, Andrew P. Longhini, et al.. (2014). Regio‐Selective Chemical‐Enzymatic Synthesis of Pyrimidine Nucleotides Facilitates RNA Structure and Dynamics Studies. ChemBioChem. 15(11). 1573–1577. 44 indexed citations
13.
Alvarado, Luigi J., Andrew P. Longhini, Regan M. LeBlanc, et al.. (2014). Chemo-Enzymatic Synthesis of Selectively 13C/15N-Labeled RNA for NMR Structural and Dynamics Studies. Methods in enzymology on CD-ROM/Methods in enzymology. 549. 133–162. 31 indexed citations
14.
Lee, Lauren, Regan M. LeBlanc, Herman Holt, et al.. (2007). Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4. Bioorganic & Medicinal Chemistry Letters. 17(21). 5897–5901. 140 indexed citations
15.
Nolan, Lawrence, Regan M. LeBlanc, Herman Holt, et al.. (2007). Design, Synthesis and Biological Testing of Cyclohexenone Derivatives of Combretastatin-A4. Letters in Drug Design & Discovery. 4(2). 144–148. 19 indexed citations
16.
Stewart, Michelle, et al.. (2006). Synthesis and Cytotoxic Properties of Chalcones: An Interactive and Investigative Undergraduate Laboratory Project at the Interface of Chemistry and Biology. Journal of Chemical Education. 83(6). 934–934. 12 indexed citations
17.
Holt, Herman, et al.. (2005). REACTION OF CHALCONES WITH BASIC HYDROGEN PEROXIDE: A STRUCTURE AND REACTIVITY STUDY. Heterocyclic Communications. 11(6). 465–470. 6 indexed citations
18.
Pati, Hari N., et al.. (2005). SYNTHESIS AND BIOLOGICAL EVALUATION OF CIS-COMBRETASTATIN ANALOGS AND THEIR NOVEL 1,2,3-TRIAZOLE DERIVATIVES. Heterocyclic Communications. 11(2). 117–120. 33 indexed citations
19.
LeBlanc, Regan M., Toni Brown, Michelle Stewart, et al.. (2005). Synthesis and cytotoxicity of epoxide and pyrazole analogs of the combretastatins. Bioorganic & Medicinal Chemistry. 13(21). 6025–6034. 81 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Аndrey V. Shernyukov Breakdown of academic impact, for papers by András Földesi Breakdown of academic impact, for papers by Surat Kumar Breakdown of academic impact, for papers by Ugo Perricone Breakdown of academic impact, for papers by Philip M. Dean Breakdown of academic impact, for papers by Charles E. Cottrell Breakdown of academic impact, for papers by Joseph Ashcroft Breakdown of academic impact, for papers by Marek Masnyk Breakdown of academic impact, for papers by Yadagiri Bathini Breakdown of academic impact, for papers by Christopher Smith
Rankless by CCL
2026